Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorazepam for IUD Insertion
NCT06496854Phase 2Withdrawn
- Sponsor
- University of Wisconsin–Madison
- Start
- Oct 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lorazepam in anxiety disorder and pain, sponsored by University of Wisconsin–Madison. Primary endpoints: Visual Analogue Scale for Pain and Visual Analogue Scale for Anxiety. Planned start Oct 2025; status: withdrawn.
02
Drugs
lorazepam
03
Conditions
anxiety disorderpain
Beyond the preview
Go deeper on NCT06496854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06496854.